Biocon has enter into collaboration with Ypsomed to customize the latter’s reusable YpsoPen for use with Biocon’s insulin cartridges. This customized reusable pen will be marketed by Biocon as INSUPen Pro in Malaysia.
Biocon has set up one of Asia’s largest integrated insulin manufacturing facility in Malaysia and has introduced its Insugen and INSUPen Pro brands in the local market recently. Ypsomed’s high quality reusable pen compliments Biocon’s Insulins product portfolio and enables Biocon to further address the growing needs of people with diabetes in Malaysia.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1870.85 |
| Dr. Reddys Labs. | 1340.55 |
| Cipla | 1456.25 |
| Zydus Lifesciences | 1102.00 |
| Lupin | 2394.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: